April Huang

April Huang currently serves as Vice President of New Business & Domain Portfolio at Ascensia Diabetes Care, where responsibilities include overseeing global portfolio strategy since April 2017. Additionally, April holds the position of Observer of the Board at Biolinq and served on the Board of Directors at POCTech Corporation from December 2020 to September 2021. Prior experience includes various leadership roles at MillerCoors from February 2006 to January 2017, where April focused on business transformation and portfolio strategy, and a managerial position at ZS Associates from July 2000 to February 2006. Educational qualifications include an MBA from Ivey Business School, a Bachelor of Commerce from McGill University, and executive education at both Northwestern University and Wharton Business School.